Multiple Sclerosis, Relapsing-Remitting Clinical Trials in Amsterdam
2 recruitingAmsterdam, Netherlands
Showing 1–2 of 2 trials
Recruiting
Multiple Sclerosis Treatment With Autologous Hematopoietic Stem Cell Transplantation in the Netherlands
Multiple Sclerosis, Relapsing-Remitting
Amsterdam UMC, location VUmc24 enrolled2 locationsNCT06567197
Recruiting
Phase 3
Non-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing MS
Demyelinating DiseasesMultiple SclerosisNervous System Diseases+3 more
Amsterdam UMC, location VUmc200 enrolled1 locationNCT05834855